Introduction
============

Dyslipidemia is a major risk factor for cardiovascular disease. Several cohort studies have reported that adults with low levels of high-density lipoprotein cholesterol (HDL-C) or extremely high levels of HDL-C had a high risk of cardiovascular disease and a high mortality rate regardless of cause^[@bib1]--[@bib3])^. In addition, low-density lipoprotein cholesterol (LDL-C) was strongly associated with cardiovascular disease or mortality when LDL-C was ≥ 190 mg/dL^[@bib2],\ [@bib3])^. The major risk factors for dyslipidemia are known to depend heavily on lifestyle, and several meta-analyses have indicated that lifestyle modifications improve the lipid and lipoprotein levels^[@bib4]--[@bib16])^. Exercise is one way of improving these levels, and a number of studies have noted the beneficial effects of regular exercise on the lipid and lipoprotein levels. Metaanalyses of studies involving exercise have mainly examined the effects of endurance exercise^[@bib10]--[@bib13])^ and resistance training^[@bib14])^, but recent analyses have examined the effects of other forms of exercise such as tai chi^[@bib15])^ and yoga^[@bib16])^ to promote health.

Aquatic exercise is a type of exercise that has recently increased in popularity^[@bib17])^ and involves characteristics specific to water, such as water temperature, resistance, hydrostatic pressure, buoyancy, and viscosity; as such, the physiological properties of aquatic exercise differ from those of land-based exercise. For example, aquatic exercise poses less of a physical burden when stationary or when moving at a low or moderate speed^[@bib18])^. Therefore, aquatic exercise can be effective as a form of exercise therapy for patients with obesity or orthopedic disease. Previous meta-analyses have suggested that aquatic exercise exerts a beneficial effect on health by lowering blood pressure^[@bib19])^ and alleviating knee pain^[@bib20])^, but no meta-analysis has examined the effects of regular aquatic exercise on the lipid and lipoprotein levels. In addition, land-based exercise and aquatic exercise result in similar levels of energy expenditure in metabolic equivalents, according to the guidelines of the American College of Sports Medicine^[@bib21])^. This suggests that aquatic exercise may be as effective as landbased exercise in terms of improving the lipid and lipoprotein levels. On the basis of this hypothesis, the purpose of the current work was to perform a metaanalysis to evaluate the effects of regular aquatic exercise on the lipid and lipoprotein levels.

Methods
=======

A meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement^[@bib22])^ and was registered in the International Prospective Register of Systematic Reviews (PROSPERO: <https://www.crd.york.ac.uk/PROSPERO>, registration number: CRD42017 075556).

Data Sources and Study Selection
--------------------------------

Databases were searched for literature published until October 2017. MEDLINE, PubMed, SPORTDiscus, the Cochrane library, and Google Scholar were searched using terms such as dyslipidemia, hyperlipidemia, lipid, lipoprotein, cholesterol, exercise, exercise therapy, physical fitness, swimming, water, aquatic exercise, and water-based exercise. The literature was comprehensively searched using different combinations of these terms. Listed references of original articles, reviews, and textbooks were also searched. The inclusion criteria for this meta-analysis were as follows: subjects had no cardiovascular or other diseases with a mean age of 20 years or older; subjects were randomly divided into an aquatic exercise group and a control group (i.e., a randomized controlled trial), with the aquatic exercise group only performing regular exercise in water and the control group not exercising, and neither group receiving intervention such as an improved diet or a change in lifestyle; the intervention lasted four weeks or longer (based on previous meta-analyses^[@bib8],\ [@bib9],\ [@bib14],\ [@bib15],\ [@bib19],\ [@bib23])^); and studies described the mean HDL-C, LDL-C, total cholesterol (TC), or triglyceride (TG) levels and their standard deviation (SD) in the exercise and control groups before and after the intervention. Studies identified from a literature search were limited to those involving aquatic exercise and those examining the effect of this exercise on the lipid and lipoprotein levels. Once these studies were identified, two authors (Y.I. and Y.N) determined whether or not the study should be included in this meta-analysis.

Data Extraction
---------------

The data and details of the intervention (mean HDL-C, LDL-C, TC or TG, and SD in the serum lipids and lipoproteins, number of subjects, type of aquatic exercise, intensity, time, frequency, details of the control group, and duration of the intervention) were extracted from studies for the meta-analysis. Some serum lipid and lipoprotein data were converted from mmol/L to mg/dL cholesterol by multiplying the values by 38.7, and TG values were multiplied by 88.7. The body mass index (BMI) was selected as a secondary outcome.

The study quality was assessed based on the Physiotherapy Evidence Database (PEDro)^[@bib24])^, with 10 terms scored at 1 point each. However, 2 points of the usual PEDro score depend on how a study is blind of subjects in groups and blind of therapists. In general, blinding of subjects is difficult in studies of exercise interventions^[@bib23])^. These 2 points were therefore excluded in this meta-analysis, and PEDro was assessed based on eight terms scored at 1 point each.

The two authors independently extracted and checked the aforementioned data and assessed the quality of the studies using the modified PEDro score.

Statistical Analyses
--------------------

The net change in HDL-C, LDL-C, TC, TG, and BMI was examined for each trial. The change was defined as the difference (values for the exercise group minus values for the control group) in changes (final values minus baseline values) in the mean. Pooled net changes were calculated with a random-effects model using the DerSimonian--Laird method and weighted by the inverse variance of differences from the baseline to the final assessment in each trial^[@bib25])^. The correlation coefficient between the baseline and the final assessment was assumed to be 0.50^[@bib26])^.

Cochran Q statistics were calculated, and the heterogeneity of pooled net change was examined among trials. The I^2^ statistic was calculated using the formula (Q−df)/Q, where df is the degree of freedom (obtained by subtracting 1 from the number of trials). The level of heterogeneity was assessed using the I^2^ statistic: low risk (less than 25%), moderate risk (25% to 75%), and high risk (greater than 75%)^[@bib27])^.

Subgroup analyses of pooled net changes in the HDL-C, LDL-C, TC, and TG levels regarding the type of aquatic exercise were performed by classifying trials into endurance exercise, no endurance exercise, swimming, and no swimming. In addition, trials were limited to aquatic endurance exercise, and subgroup analyses were performed for eight categories: women only, women and men, mean age (≥ 60 years and \< 60 years), intervention duration (≥ 8 weeks and ≥ 12 weeks), dyslipidemia, and no dyslipidemia. On the basis of the American Heart Association and the American College of Sports Medicine guidelines on physical activity to maintain health^[@bib28])^, endurance exercise was defined as exercise that was moderate to vigorous in activity and that lasted a minimum of 30 min per session. "Dyslipidemia" was defined based on the Japan Atherosclerosis Society guidelines^[@bib29])^, and trials with a mean HDL-C \< 40 mg/dL, mean LDL-C ≥ 140 mg/dL, or mean TG ≥ 150 mg/dL of subjects were designated as having dyslipidemic subjects.

Two methods were used to evaluate any publication bias, i.e. the symmetry of funnel plots produced by the net changes in serum lipids or lipoproteins (x-axis) and the inverse of the standard error (y-axis) were assessed. First, the trim and fill method of Duval and Tweedie was used to estimate the number of missing trials^[@bib30])^. If the results suggested that trials were missing, then pooled net changes in lipids and lipoproteins were adjusted in light of the effect of these trials. Second, Egger\'s regression test was used to evaluate the asymmetry of funnel plots^[@bib31])^.

The results for baseline variables were expressed as the mean ± SD weighted by the number of subjects, and comparisons of the exercise group and control group were carried out by the Mann--Whitney test. In all the statistical tests, a *P* value \< 0.05 was considered to be statistically significant. The results of net changes were expressed as the 95% confidence intervals (CI). The Comprehensive Meta-Analysis soft program (Version 2.2; Biostat, Inc., Englewood, NJ, USA) was used to perform the meta-analysis and assess the publication bias. Other statistical tests were performed using the SPSS soft program (Version 21.0; IBM Inc., Armonk, NY, USA).

Results
=======

Study Selection
---------------

As a result of a literature search, 42 studies were identified as involving aquatic exercise and describing lipid or lipoprotein data. Of these, 31 studies did not meet the selection criteria and were excluded from the meta-analysis (**[Fig. 1](#F1){ref-type="fig"}**). As a result, 12 trials in 11 articles (1 article included 2 trials)^[@bib32]--[@bib42])^ were ultimately analyzed.

![PRISMA flow diagram regarding article selection for meta-analysis.](jat-26-14-g001){#F1}

Trial Characteristics
---------------------

All trials had a parallel design and were in English. **[Table 1](#T1){ref-type="table"}** shows the characteristics of each included trial. The trials involved 393 subjects in total: 208 subjects in the exercise groups and 185 subjects in the control groups. Eleven trials^[@bib32]--[@bib34],\ [@bib36]--[@bib42])^ reported the number of subjects by sex. These trials involved 16 males (4.5%) and 337 females (95.5%). Ten trials^[@bib32]--[@bib34],\ [@bib36],\ [@bib37],\ [@bib39]--[@bib42])^ reported the mean age of subjects, which ranged from 46 to 73 years (median: 62 years). Ten trials^[@bib32],\ [@bib34]--[@bib39],\ [@bib41],\ [@bib42])^ carried out endurance exercise, one trial carried out endurance exercise plus resistance training^[@bib33])^, and one trial carried out exercise under 30 min^[@bib40])^. Three trials^[@bib34],\ [@bib40])^ carried out only swimming. Five trials^[@bib34],\ [@bib35],\ [@bib38],\ [@bib41],\ [@bib42])^ used the heart rate to gauge the intensity of exercise. All trials involved a set exercise time and frequency. An exercise session ranged from 15 to 60 min. The frequency of exercise was 1--4 sessions per week. The water temperature ranged from 26 to 36°C according to the six trials^[@bib32],\ [@bib35]--[@bib37],\ [@bib39],\ [@bib41])^ that reported the temperature. The duration of intervention ranged from 6 to 24 weeks (median: 12 weeks). **[Supplementary Table 1](#T3){ref-type="table"}** shows the PEDro on each trial, and the score ranged from 3 to 7 points (median: 5 points).

###### Characteristics of included trials

  Study name                                             Subjects   Female (%)   Mean age (years)   Exercise intervention                                                                                                                                                                                                                                                                                                          
  ------------------------------------------------------ ---------- ------------ ------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------- ------ ---- ----------
  Takeshima *et al*^[@bib32])^, 2002, Japan              30         100          69                 Endurance-type exercise (walking and dancing) and resis-tance exercise, and V̇O~2~ at LT                                                                                                                                                                                                                   40       3      12   30
  Colado *et al*^[@bib33])^, 2009, Spain                 25         100          54                 8 exercises on circuit, 20 repetitions per set on 1 -- 3 sets (week 1--12), 10 exercises on circuit and 20 repetitions/set on 3 sets (13--18), and 8 exercises on circuit and 15 repetitions/set on 2 sets of supersets (week 19--24), and OMNI scale of 5 (week 1--4) and OMNI scale of 7 (week 5--24)   35--60   2--3   24   NR
  Nualnim *et al*^[@bib34])^, 2012, United States        43         74           60                 Swimming, and less than 60 HR~max~ (first few weeks) and 70--75% HR~max~                                                                                                                                                                                                                                  15--45   3--4   12   NR
  Nuttamonwarakul *et al*^[@bib35])^, 2012, Thailand     40         NR           60--               Aqua-aerobic exercise and 70% HR~max~ or a Borg scale of 10--16                                                                                                                                                                                                                                           30       3      12   34--36
  Shibata *et al*^[@bib36])^, 2012, Japan                22         81           68                 Walking (side-walking, back-walking, twist-walking, hurdler-walking, and cross-walking) and a Borg scale of 11--13                                                                                                                                                                                        30       1      10   32
  Arca *et al*^[@bib37])^, 2013, Brazil                  33         100          64                 Walking and running, and 50--60% HRR deducted 17 heartbeat                                                                                                                                                                                                                                                50       3      12   33--33.5
  Rahimi *et al*^[@bib38])^, 2013, Iran                  24         100          45--55             Walking and 50--70% HR~max~                                                                                                                                                                                                                                                                               35       3      6    NR
  Chung *et al*^[@bib39])^, 2014, China                  23         100          72                 Water tai chi (24-Form)                                                                                                                                                                                                                                                                                   50       3      8    32
  Mohr *et al*^[@bib40])^, 2014a, UK and Faroe Islands   41         100          45                 Intermittent swimming by free-style (front crawl) and 6--10 (1--6 week: 6 interval; 7--12 week: 8 interval; 13--15: 10 interval) × 30 s, and all-out (interspersed by 2 min recovery)                                                                                                                     15--25   2.9    15   NR
  Mohr *et al*^[@bib40])^, 2014b, UK and Faroe Islands   41         100          46                 Continuous swimming by free-style (front crawl) and encour-aged to swim as far as possible                                                                                                                                                                                                                60       2.9    15   NR
  Kantyka *et al*^[@bib41])^, 2015, Poland               21         100          56                 Aqua--aerobics comprised running and arm exercise and maintained at approximately 128--137 bpm of target HR                                                                                                                                                                                               25--30   3      14   26--28
  Kim *et al*^[@bib42])^, 2016, Korea                    50         100          72                 Aquarobics and maintained at about 129--138 bpm of tar-get HR                                                                                                                                                                                                                                             50       3      12   NR

Borg scale: Borg rating of perceived exertion scale; HR: heart rate; HR~max~: maximal heart rate; HRR: heart rate reserve; NR: not reported; LT: lactate threshold; V̇O~2~: oxygen uptake; V̇O~2max~: maximal oxygen uptake; WT: water temperature.

###### Study quality based on PEDro

  Study name                                 Items   Total Score                                             
  ------------------------------------------ ------- ------------- ----- ----- ----- ----- ----- ----- ----- ---
  Takeshima *et al*^[@bib32])^, 2002         Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Colado *et al*^[@bib33])^, 2009            Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Nualnim *et al*^[@bib34])^, 2012           Yes     No            Yes   Yes   Yes   Yes   No    Yes   Yes   7
  Nuttamonwarakul *et al*^[@bib35])^, 2012   Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Shibata *et al*^[@bib36])^, 2012           Yes     No            Yes   Yes   Yes   Yes   Yes   Yes   Yes   7
  Arca *et al*^[@bib37])^, 2013              Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Rahimi *et al*^[@bib38])^, 2013            Yes     No            No    Yes   No    No    No    Yes   Yes   3
  Chung *et al*^[@bib39])^, 2014             Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Mohr *et al*^[@bib40])^, 2014a             Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Mohr *et al*^[@bib40])^, 2014b             Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Kantyka *et al*^[@bib41])^, 2015           Yes     No            Yes   Yes   No    No    Yes   Yes   Yes   5
  Kim *et al*^[@bib42])^, 2016               Yes     No            No    Yes   No    No    Yes   Yes   Yes   4

1: Random allocated to groups, 2: Concealed allocation, 3: Groups that were similar at baseline, 4: The blinding of assessors, 5: Outcome measures that were obtained from more than 85% of subjects, 6: Intention to treat analysis, 7: Between-group statistical comparisons, 8: Provided both point measures and measures of variability, 9: Eligibility criteria (note: eligibility criteria does not contribute to total score).

Net Changes and Subgroup Analysis
---------------------------------

**[Figs.2](#F2){ref-type="fig"}--[5](#F5){ref-type="fig"}** show the results of baseline and forest plots of net changes in lipids and lipoproteins from each trial and the pooled net changes in lipids and lipoproteins. The pooled net changes in HDL-C, LDL-C, and TC in the trials of aquatic endurance exercise decreased significantly. The figures include the baseline HDL-C, LDL-C, TC, and TG levels and net changes in these levels according to trials not involving aquatic endurance exercise, and the pooled net changes did not improve significantly. The pooled net changes in LDL-C and TC decreased significantly in all the trials. In addition, the pooled net changes in HDL-C, LDL-C, TC, and TG did not improve significantly in trials involving swimming^[@bib34],\ [@bib40])^, and the pooled net changes in LDL-C and TC improved significantly in trials not involving swimming (**[Supplementary Table 2](#T4){ref-type="table"}**)^[@bib32],\ [@bib33],\ [@bib35]--[@bib39],\ [@bib41],\ [@bib42])^.

![Baseline HDL-C and forest plot for the net changes in HDL-C. Each trial is represented with black squares (net change) and widths (95% CI); the size of the black squares is in proportion to the weighting by inverse variance in each trial. The pooled net changes are represented by black rhombuses (net change) and widths (95% CI).](jat-26-14-g002){#F2}

![Baseline LDL-C and forest plot for the net changes in LDL-C. Each trial is represented with black squares (net change) and widths (95% CI); the size of the black squares is in proportion to the weighting by inverse variance in each trial. The pooled net changes are represented by black rhombuses (net change) and widths (95% CI).](jat-26-14-g003){#F3}

![Baseline TC and forest plot for the net changes in TC. Each trial is represented with black squares (net change) and widths (95% CI); the size of the black squares is in proportion to the weighting by inverse variance in each trial. The pooled net changes are represented by black rhombuses (net change) and widths (95% CI).](jat-26-14-g004){#F4}

![Baseline TG and forest plot for the net changes in TG. Each trial is represented with black squares (net change) and widths (95% CI); the size of the black squares is in proportion to the weighting by inverse variance in each trial. The pooled net changes are represented by black rhombuses (net change) and widths (95% CI).](jat-26-14-g005){#F5}

###### Baseline, net changes, and subgroup analyses when RCTs limited involving swimming or no swimming

  Variable (category)   Trials    Baseline, mg/dL   Net change, mg/dL       Q                                     I^2^%
  --------------------- --------- ----------------- ----------------------- ------------------------------------- -------
  **HDL-C**                                                                                                       
      Swimming          3 (125)   54.6 ± 12.9       5.3 (−1.1 to 11.7)      0.3                                   0.0
      No swimming       8 (228)   52.1 ± 10.7       2.0 (−3.2 to 7.1)       17.1[\*](#tf2){ref-type="table-fn"}   59.0
  **LDL-C**                                                                                                       
      Swimming          3 (125)   138.0 ± 27.1      −0.6 (−14.4 to 13.2)    0.01                                  0.0
      No swimming       8 (228)   147.8 ± 22.4      −13.1 (−23.7 to −2.6)   12.7                                  45.0
  **TC**                                                                                                          
      Swimming          3 (125)   211.9 ± 28.2      −4.0 (−17.7 to 9.8)     1.5                                   0.0
      No swimming       7 (223)   227.3 ± 24.0      −11.3 (−21.8 to −0.8)   10.3                                  41.9
  **TG**                                                                                                          
      Swimming          3 (125)   107.7 ± 34.7      −24.2 (−48.8 to 0.4)    2.3                                   14.1
      No swimming       9 (268)   143.3 ± 40.2      −10.8 (−27.8 to 6.1)    21.8[\*](#tf2){ref-type="table-fn"}   63.3

CI: confidence intervals; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride.

Trials are expressed number of trials (number of subjects)

Baseline lipids and lipoproteins are expressed as mean ± SD

Net changes in lipids and lipoproteins are expressed as pooled net change (95% CI)

Significant heterogeneity (*P* \< 0.05)

**[Table 2](#T2){ref-type="table"}** shows the results of the subgroup analyses when trials were limited to those involving subjects who performed endurance exercise^[@bib32],\ [@bib34]--[@bib39],\ [@bib41],\ [@bib42])^. When trials were limited to those involving only women^[@bib32],\ [@bib33],\ [@bib37]--[@bib42])^, the pooled net changes in HDL-C, LDL-C, and TC improved significantly, but LDL-C contained significant heterogeneity. When trials were limited to those involving subjects with a mean age \< 60 years, the pooled net changes in HDL-C, TC, and TG improved significantly. When trials were limited to those involving subjects with dyslipidemia^[@bib35],\ [@bib38]--[@bib42])^, the pooled net changes in HDLC, LDL-C, TC, and TG improved significantly, but TG contained significant heterogeneity. When trials were limited to those involving subjects without dyslipidemia^[@bib32]--[@bib34],\ [@bib36],\ [@bib37])^, the pooled net changes in HDL-C improved significantly.

###### Baseline, net changes, and subgroup analyses when trials are limited to aquatic endurance exercise

  Variable (category)                                   Trials    Baseline, mg/dL   Net change, mg/dL       Q                                     I^2^ %
  ----------------------------------------------------- --------- ----------------- ----------------------- ------------------------------------- --------
  **HDL-C**                                                                                                                                       
      Women only                                        7 (222)   48.9 ± 11.1       5.0 (0.6 to 9.4)        9.7                                   38.2
      Women and men                                     2 (65)    59.8 ± 12.2       1.3 (−7.0 to 9.6)       0.4                                   0.0
      Mean age \< 60 years                              3 (86)    51.2 ± 11.1       8.4 (3.7 to 13.1)       0.9                                   0.0
      Mean age ≥ 60 years                               6 (201)   51.5 ± 11.4       2.2 (−2.9 to 7.4)       7.7                                   35.3
      Intervention duration ≥ 8 weeks                   8 (263)   53.0 ± 11.8       3.4 (−0.5 to 7.4)       8.3                                   15.8
      Intervention duration ≥ 12 weeks                  6 (218)   51.8 ± 11.6       5.5 (1.6 to 9.4)        3.5                                   0.0
      Dyslipidemia                                      4 (118)   50.8 ± 11.5       6.4 (2.0 to 10.8)       6.4                                   53.0
      No dyslipidemia                                   5 (169)   51.7 ± 11.2       4.4 (0.01 to 8.8)       4.3                                   8.2
  **LDL-C**                                                                                                                                       
      Women only                                        7 (222)   149.3 ± 23.6      −12.3 (−23.6 to −1.0)   13.7[\*](#tf1){ref-type="table-fn"}   56.3
      Women and men                                     2 (65)    133.8 ± 26.2      −6.1 (−22.9 to 10.6)    0.2                                   0.0
      Mean age \< 60 years                              3 (86)    147.5 ± 20.9      −16.0 (−36.0 to 4.1)    5.3                                   62.2
      Mean age ≥ 60 years                               6 (201)   145.0 ± 25.5      −6.6 (−16.2 to 3.0)     5.2                                   3.9
      Intervention duration ≥ 8 weeks                   8 (263)   144.7 ± 25.2      −6.2 (−14.6 to 2.2)     5.5                                   0.0
      Intervention duration ≥ 12 weeks                  6 (218)   140.6 ± 23.9      −5.5 (−15.3 to 4.3)     5.4                                   7.7
      Dyslipidemia                                      4 (118)   156.3 ± 26.0      −17.3 (−31.7 to −2.9)   5.9                                   49.3
      No dyslipidemia                                   5 (169)   139.3 ± 23.1      −6.3 (−17.5 to 4.9)     5.2                                   23.1
  **TC**                                                                                                                                          
      Women only                                        6 (199)   225.7 ± 20.6      −9.9 (−17.8 to −2.0)    9.5                                   47.8
      Women and men                                     1 (43)    206.0 ± 31.8      9.0 (−16.4 to 34.4)     0.0                                   0.0
      Mean age \< 60 years                              3 (86)    224.8 ± 22.2      −16.9 (−32.1 to −1.7)   0.2                                   0.0
      Mean age ≥ 60 years                               5 (196)   222.2 ± 26.9      −2.6 (−17.5 to 12.4)    11.5[\*](#tf1){ref-type="table-fn"}   65.1
      Intervention duration ≥ 8 weeks (or ≥ 12 weeks)   7 (258)   222.1 ± 26.5      −6.2 (−17.5 to 5.0)     11.9                                  49.0
      Dyslipidemia                                      4 (135)   225.8 ± 28.0      −15.0 (−28.1 to −1.8)   0.5                                   0.0
      No dyslipidemia                                   4 (147)   220.8 ± 23.4      −0.4 (−19.0 to 18.2)    11.5[\*](#tf1){ref-type="table-fn"}   73.8
  **TG**                                                                                                                                          
      Women only                                        7 (222)   141.2 ± 30.8      −10.4 (−31.5 to 10.6)   21.5[\*](#tf1){ref-type="table-fn"}   72.1
      Women and men                                     2 (65)    118.0 ± 66.0      −17.6 (−72.3 to 37.1)   1.8                                   45.9
      Mean age \< 60 years                              3 (84)    144.6 ± 27.0      −36.9 (−66.0 to −7.8)   4.0                                   50.6
      Mean age ≥ 60 years                               7 (241)   137.7 ± 44.3      −1.9 (−15.4 to 11.6)    7.8                                   22.9
      Intervention duration ≥ 8 weeks                   9 (303)   131.4 ± 41.9      −5.0 (−16.8 to 6.8)     9.7                                   17.2
      Intervention duration ≥ 12 weeks                  7 (258)   132.8 ± 32.0      −4.4 (−16.7 to 7.9)     7.6                                   20.6
      Dyslipidemia                                      5 (158)   149.0 ± 34.2      −26.3 (−50.9 to −1.7)   8.0                                   50.0
      No dyslipidemia                                   5 (169)   131.6 ± 45.0      0.4 (−17.8 to 18.5)     7.1                                   43.4

CI: confidence intervals; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride.

Trials are expressed as the number of trials (number of subjects).

Baseline lipids and lipoproteins are expressed as the mean ± SD.

Trials with a mean HDL-C \< 40 mg/dL, mean LDL-C ≥ 140 mg/dL, or mean TG ≥ 150 mg/dL of subjects were designated as having dyslipidemic subjects.

Net changes in lipids and lipoproteins are expressed as pooled net change (95% CI).

Significant heterogeneity (*P* \< 0.05).

BMI was examined as a secondary outcome. The baseline BMI was 26.5 ± 4.4 kg/m^2^ (404 subjects in 11 trials^[@bib32]--[@bib35],\ [@bib37]--[@bib42])^). The pooled net change in BMI was −0.2 kg/m^2^ (95% CI, −1.1 to 0.7 for 297 subjects in 9 trials^[@bib32]--[@bib35],\ [@bib37],\ [@bib39]--[@bib41])^), and no significant heterogeneity in the BMI was noted (*P* = 0.99 and I^2^ = 0.0%).

**[Supplementary Fig.1](#F6){ref-type="fig"}--[4](#F9){ref-type="fig"}** show the results of funnel plots in lipids and lipoproteins. When the publication bias was evaluated using the trim and fill method, there were no missing trials for TG. However, there were five missing trials for HDL-C, five missing trials for LDL-C, and two missing trials for TC. After adjusting for the missing trials, the pooled net changes in HDL-C improved to 7.4 mg/dL (95% CI, 3.1 to 11.8), those in LDL-C improved to −18.9 mg/dL (95% CI, −28.3 to −9.5), and those in TC improved to −8.5 mg/dL (95% CI, −15.5 to −1.5). Egger\'s regression test revealed significant asymmetry of the funnel plots of HDL-C and LDL-C (*P* = 0.01 and *P* = 0.03, respectively). In a subgroup analysis where trials were limited to those involving subjects who performed swimming alone, subjects with dyslipidemia, or subjects without dyslipidemia, the funnel plots for HDL-C, LDL-C, TC, and TG were not significantly asymmetrical and the trim and fill method of Duval and Tweedie suggested that there were no missing trials (**[Supplementary Table 3](#T5){ref-type="table"}**).

![Funnel plot of HDL-C for each trial. Egger\'s regression test indicated that the funnel plot had significant asymmetry. A vertical line indicates the pooled net change in HDL-C (3.1 mg/dL). The trim and fill method of Duval and Tweedie suggested that there were five missing trials (white circles). A dotted vertical line indicates the pooled net change in HDL-C after adjusting for the missing trials (7.4 mg/dL).](jat-26-14-g006){#F6}

![Funnel plot for LDL-C for each trial. Egger\'s regression test indicated that the funnel plot had significant asymmetry. A vertical line indicates the pooled net change in LDL-C (−10.1 mg/dL). The trim and fill method of Duval and Tweedie suggested that there were five missing trials (white circles). A dotted vertical line indicates the pooled net change in LDL-C after adjusting for the missing trials (−18.9 mg/dL).](jat-26-14-g007){#F7}

![Funnel plot for TC for each trial. Egger\'s regression test indicated that the funnel plot had significant asymmetry. A vertical line indicates the pooled net change in TC (−9.5 mg/dL). The trim and fill method of Duval and Tweedie suggested that there were two missing trials (white circles). A dotted vertical line indicates the pooled net change in TC after adjusting for the missing trials (−8.5 mg/dL).](jat-26-14-g008){#F8}

![Funnel plot of TG for each trial. Egger\'s regression test indicated that the funnel plot did not have significant asymmetry. A vertical line indicated the pooled net change in TG (−13.7 mg/dL). The trim and fill method of Duval and Tweedie did not suggest that there were any missing trials.](jat-26-14-g009){#F9}

###### Publication bias

  Variable (category)                                   Trials   Net change, mg/dL        Trim and fill method   Regression test                 
  ----------------------------------------------------- -------- ------------------------ ---------------------- ------------------------ ------ ------
  **HDL-C**                                                                                                                                      
      All trials                                        11       3.1 (−0.8 to 6.9)        5                      7.4 (3.1 to 11.8)        −3.3   0.01
      Endurance exercise                                9        4.6 (0.8 to 8.3)         4                      8.0 (3.7 to 12.2)        −3.2   0.01
      No endurance exercise                             2        −2.1 (−13.4 to 9.2)      N/A                                             N/A    
      Swimming                                          3        5.3 (−1.1 to 11.7)       0                                               −3.1   0.70
      No swimming                                       8        2.0 (−3.2 to 7.1)        4                      7.3 (1.7 to 12.8)        −4.3   0.01
      Women only                                        7        5.0 (0.6 to 9.4)         2                      7.2 (2.3 to 12.2)        −3.4   0.02
      Women and men                                     2        1.3 (-7.0 to 9.6)        N/A                                             N/A    
      Mean age \< 60 years                              3        8.4 (3.7 to 13.1)        2                      9.8 (5.7 to 13.9)        −1.6   0.30
      Mean age ≥ 60 years                               6        2.2 (−2.9 to 7.4)        3                      6.1 (0.7 to 11.5)        −3.9   0.02
      Intervention duration ≥ 8 weeks                   8        3.4 (−0.5 to 7.4)        3                      6.0 (1.6 to 10.4)        −3.3   0.03
      Intervention duration ≥ 12 weeks                  6        5.5 (1.6 to 9.4)         3                      8.0 (4.3 to 11.7)        −2.3   0.11
      Dyslipidemia                                      4        6.4 (2.0 to 10.8)        0                                               −3.1   0.20
      No dyslipidemia                                   5        4.4 (0.01 to 8.8)        2                      6.2 (1.6 to 10.7)        −3.2   0.04
  **LDL-C**                                                                                                                                      
      All trials                                        11       −10.1 (−18.8 to −1.4)    5                      −18.9 (−28.3 to −9.5)    3.2    0.03
      Endurance exercise                                9        −10.1 (−20.2 to −0.03)   4                      −18.4 (−28.9 to −7.9)    3.6    0.02
      No endurance exercise                             2        −8.3 (−27.7 to 11.2)     N/A                                             N/A    
      Swimming                                          3        −0.6 (−14.4 to 13.2)     0                                               −3.3   0.62
      No swimming                                       8        −13.1 (−23.7 to −2.6)    4                      −22.1 (−33.3 to −11.0)   2.9    0.09
      Women only                                        7        −12.3 (−23.6 to −1.0)    3                      −20.0 (−33.3 to −6.7)    3.6    0.06
      Women and men                                     2        −6.1 (−22.9 to 10.6)     N/A                                             N/A    
      Mean age \< 60 years                              3        −16.0 (−36.0 to 4.1)     2                      −30.5 (−50.6 to −10.5)   3.9    0.19
      Mean age ≥ 60 years                               6        −6.6 (−16.2 to 3.0)      1                      −3.9 (−13.1 to 5.4)      1.8    0.50
      Intervention duration ≥ 8 weeks                   8        −6.2 (−14.6 to 2.2)      0                                               1.6    0.43
      Intervention duration ≥ 12 weeks                  6        −5.5 (−15.3 to 4.3)      0                                               4.0    0.30
      Dyslipidemia                                      4        −17.3 (−31.7 to −2.9)    2                      −23.2 (−37.9 to −8.4)    2.9    0.10
      No dyslipidemia                                   5        −6.3 (−17.5 to 4.9)      0                                               7.5    0.19
  **TC**                                                                                                                                         
      All trials                                        10       −9.5 (−17.7 to −1.3)     2                      −8.5 (−15.5 to −1.5)     0.7    0.33
      Endurance exercise                                8        −8.5 (−16.5 to −0.5)     1                      −6.8 (−13.1 to −0.5)     1.0    0.27
      No endurance exercise                             2        −14.0 (−31.2 to 3.3)     N/A                                             N/A    
      Swimming                                          3        −4.0 (−17.7 to 9.8)      0                                               3.3    0.75
      No swimming                                       7        −11.3 (−21.8 to −0.8)    2                      −8.3 (−16.0 to −0.6)     0.5    0.61
      Women only                                        6        −9.9 (−17.8 to −2.0)     2                      −5.9 (−16.8 to 5.0)      0.8    0.49
      Women and men                                     1        9.0 (−16.4 to 34.4)      N/A                                             N/A    
      Mean age \< 60 years                              3        −16.9 (−32.1 to −1.7)    0                                               −1.1   0.72
      Mean age ≥ 60 years                               5        −2.6 (−17.5 to 12.4)     0                                               2.0    0.15
      Intervention duration ≥ 8 weeks (or ≥ 12 weeks)   7        −6.2 (−17.5 to 5.0)      0                                               1.2    0.22
      Dyslipidemia                                      4        −15.0 (−28.1 to −1.8)    1                      −13.6 (−25.7 to −1.5)    −1.2   0.67
      No dyslipidemia                                   4        −0.4 (−19.0 to 18.2)     0                                               2.5    0.18
  **TG**                                                                                                                                         
      All trials                                        12       −13.7 (−27.8 to 0.5)     0                                               −0.2   0.85
      Endurance exercise                                10       −12.0 (−28.8 to 4.9)     0                                               0.0    0.97
      No endurance exercise                             2        −20.2 (−46.2 to 5.8)     N/A                                             N/A    
      Swimming                                          3        −24.2 (−48.8 to 0.4)     0                                               4.8    0.60
      No swimming                                       9        −10.8 (−27.8 to 6.1)     0                                               0.0    0.97
      Women only                                        7        −10.4 (−31.5 to 10.6)    1                      −15.1 (−35.4 to 5.2)     0.2    0.88
      Women and men                                     2        −17.6 (−72.3 to 37.1)    N/A                                             N/A    
      Mean age \< 60 years                              3        −36.9 (−66.0 to −7.8)    2                      −56.5 (−86.3 to −26.7)   4.0    0.34
      Mean age ≥ 60 years                               7        −1.9 (−15.4 to 11.6)     0                                               0.5    0.58
      Intervention duration ≥ 8 weeks                   9        −5.0 (−16.8 to 6.8)      0                                               0.1    0.87
      Intervention duration ≥ 12 weeks                  7        −4.4 (−16.7 to 7.9)      0                                               0.4    0.63
      Dyslipidemia                                      5        −26.3 (−50.9 to −1.7)    2                      −39.5 (−63.7 to −15.3)   −4.3   0.03
      No dyslipidemia                                   5        0.4 (−17.8 to 18.5)      0                                               0.6    0.63

CI: confidence intervals; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; N/A: not available; TC: total cholesterol; TG: triglyceride.

Net changes in lipids and lipoproteins are expressed as pooled net change (95% CI).

Trials with a mean HDL-C \< 40 mg/dL, mean LDL-C ≥ 140 mg/dL, or mean TG ≥ 150 mg/dL of subjects were designated as having dyslipidemia of subjects.

Discussion
==========

According to previous meta-analyses, regular endurance exercise resulted in pooled net changes in HDL-C of approximately 2 mg/dL, pooled net changes in LDL-C of approximately −4 mg/dL, pooled net changes in TC of approximately −4 mg/dL, and pooled net changes in TG of approximately −2 mg/dL^[@bib10]--[@bib13])^. In addition, resistance training resulted in pooled net changes in HDL-C of 0.7 mg/dL, pooled net changes in LDL-C of −6.1 mg/dL, pooled net changes in TC of −5.5 mg/dL, and pooled net changes in TG of −8.1 mg/dL, but HDL-C did not improve significantly^[@bib14])^. The current meta-analysis evaluated the effects of aquatic exercise on the lipid and lipoprotein levels. The results indicated that exercise resulted in pooled net changes in HDL-C of 3.1 mg/dL, pooled net changes in LDL-C of −10.1 mg/dL, pooled net changes in TC of −9.5 mg/dL, and pooled net changes in TG of −13.7 mg/dL, but the pooled net changes in HDL-C and TG did not improve significantly and contained significant heterogeneity.

When trials were limited to those involving subjects who performed endurance exercise, the HDL-C, LDL-C, and TC levels improved significantly, and subgroup analyses revealed beneficial effects on the lipid and lipoprotein levels in women, subjects with a mean age \< 60 years, and patients with dyslipidemia. In addition, the current meta-analysis revealed greater improvement in lipid and lipoprotein levels than previous meta-analyses^[@bib10]--[@bib14])^, likely because of the influence of baseline dyslipidemia. The baseline LDL-C, TC, and TG levels in the current study were higher than those in previous meta-analyses^[@bib8]--[@bib11],\ [@bib14])^. Several meta-analyses have indicated that changes in the lipid and lipoprotein levels are related to the baseline lipid and lipoprotein levels^[@bib7],\ [@bib8])^. However, the current study showed that HDL-C improved significantly in trials involving endurance exercise and subjects without dyslipidemia. Thus, aquatic endurance exercise is expected to increase the HDL-C levels, regardless of whether a subject has dyslipidemia or not. In addition, the current study showed that the HDL-C levels improved significantly when trials were limited to those involving an intervention duration ≥ 12 weeks. Previous meta-analyses have similarly suggested that the exercise time or volume might be associated with the effects of exercise on the lipid and lipoprotein levels^[@bib7],\ [@bib8],\ [@bib13])^. For example, a meta-analysis reported that the HDL-C levels increased by approximately 1.4 mg/dL for every 10 min an exercise session was prolonged^[@bib13])^. The current meta-analysis involved trials lasting a minimum of 30 min per session, but previous meta-analyses included trials of \< 30 min per session^[@bib11]--[@bib13])^.

The mechanisms by which exercise improved the lipid and lipoprotein levels are still unclear. However, given that adipocytokines are considered to cause dyslipidemia^[@bib43])^, improvements in lipid and lipoprotein metabolism are presumably related to changes in the adipocytokine levels. A large randomized controlled trial reported that both HDL-C and adiponectin levels increased as a result of lifestyle management and that changes in HDL-C levels were associated with changes in adiponectin levels^[@bib44])^. A recent meta-analysis also indicated that endurance exercise reduced the serum leptin levels and increased the adiponectin levels^[@bib45])^, so endurance exercise may alleviate dyslipidemia via changes in adipocytokine levels.

A meta-analysis suggested that exercise therapy was as effective at preventing cardiovascular disease as drug therapy^[@bib46])^. Because dyslipidemia is a risk factor for cardiovascular disease^[@bib1]--[@bib3])^ and regular exercise improves the lipid and lipoprotein levels^[@bib10]--[@bib16])^, improved lipid and lipoprotein levels may prevent cardiovascular disease. The mechanism by which exercise prevents cardiovascular disease is thought to be by improving the vascular function. A meta-analysis reported that endurance exercise on land significantly improved the pulse wave velocity^[@bib47])^. A cross-sectional study indicated that pulse wave velocity was associated with the HDL-C, TC, and TG levels^[@bib48])^. In addition, a controlled clinical trial involving regular aquatic exercise indicated that the percentage change in LDL-C or TC during intervention was related to the percentage change in pulse wave velocity during intervention^[@bib49])^. A randomized controlled trial included in the current meta-analysis examined the related vascular function and indicated that swimming training significantly increased the carotid artery compliance^[@bib34])^. However, that study found that the lipid and lipoprotein levels did not change significantly from the baseline to after intervention. Because there is little evidence indicating the mechanism by which regular aquatic exercise affects the relationship between the vascular function and lipid or lipoprotein levels, this mechanism is a topic for future study.

The current meta-analysis had several limitations. First, this meta-analysis has a small sample of only 393 subjects, and most were older and/or female. In addition, publication bias was suspected of affecting the net changes in HDL-C, LDL-C, and TC. Once these influences were taken into account and adjusted for, the pooled net changes in HDL-C and LDL-C improved drastically. When trials were limited to those involving women or subjects ≥ 60 years of age, there were no signs of publication bias with regard to LDL-C, TC, and TG. Therefore, new randomized controlled trials --- particularly those involving men and subjects \< 60 years of age---should be included in a future meta-analysis. Second, this meta-analysis did not perform a subgroup analysis of the effects of baseline levels of lipids and lipoproteins based on the guidelines of the American College of Cardiology and the American Heart Association^[@bib2])^. According to these guidelines, statin therapy is indicated when a patient\'s LDL-C level is ≥ 190 mg/dL (70--189 mg/dL if a patient has diabetes), a patient has atherosclerotic cardiovascular disease, or a patient has a 10-year risk of developing atherosclerotic cardiovascular disease ≥ 7.5%^[@bib2])^. The current meta-analysis suggested that not all the trial subjects met these criteria based on their mean LDL-C levels at the baseline, and patients with cardiovascular disease and those undergoing cardiac rehabilitation were excluded as subjects. Therefore, the current meta-analysis did not analyze individuals who needed to take statins. A cohort study reported that statin therapy and increased fitness were independently associated with mortality^[@bib50])^. Thus, the combination of statin therapy and increased physical activity is a crucial way of improving the health in patients with dyslipidemia. However, there is little evidence regarding the efficacy of the combination of exercise and statin therapy, so future studies should evaluate the effects of exercise on the lipid and lipoprotein levels (in individuals at risk of developing dyslipidemia).

Conclusion
==========

The results of a meta-analysis indicated that aquatic endurance exercise improved the lipid and lipoprotein levels. This form of exercise particularly benefited women, the middle-aged, and patients with dyslipidemia. However, the current meta-analysis had a small sample size, so additional trials must be included in the future in order to confirm the effects of regular aquatic exercise on lipid and lipoprotein levels.
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